Minerva Neurosciences
NASDAQ: NERVWaltham, US · Massachusetts corporation · 4 known investors
Find your way into Minerva Neurosciences
43 people in our graph share verified history with the Minerva Neurosciences team — schools, employers, funds. One of them is your warm intro.
Giovanni Mariggiunlockedknows Rémy Luthringer · together at Medicxi
×11knows the team · via Medicxi
Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders. It focuses on designing clinical trials with endpoints tied to patient benefit.
Founders & leadership
JR
Joseph ReillyExecutive
GR
Geoff RaceinPresident2014–2026
FA
Fred AhlholminExecutive
RL
ML
Mark LevineExecutive
Board
MO
FD
JV
Jan Van HeekBoard director
NV
Nico VandervelpenBoard director
MB
Investors · 4
Reported raises · per SEC filings
Form D private placements$32M disclosed across 2 of 4 rounds · 2015–2025
▶$20MofferedJul 2023 · 4 investors · BiotechnologyRule 506(b)
▶$20MofferedJul 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fouzia Laghrissi-ThodeDirector
- Jan van HeekDirector
- David KupferDirector
- Jeryl HillemanDirector
- Hans Peter HaslerDirector
- Geoffrey RaceExecutive Officer
- Remy LuthringerExecutive Officer, Director
- Frederick AhlholmExecutive Officer
- Offering amount
- $20M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedMar 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedMar 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fouzia Laghrissi-ThodeDirector
- Fred AhlholmExecutive Officer
- David KupferDirector
- Geoff RaceExecutive Officer
- Mark LevineExecutive Officer
- Remy LuthringerExecutive Officer, Director
- Joseph ReillyExecutive Officer
- Jan Van HeekDirector
- Francesco De RubertisDirector
- Michele OllierDirector
- Nico VandervelpenDirector
- Marc BeerDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31MraisedMar 2015 · 22 investors · BiotechnologyRule 506(b)
▶$31MraisedMar 2015 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jan Van HeekDirector
- Joseph ReillyExecutive Officer
- Nico VandervelpenDirector
- Geoff RaceExecutive Officer
- Fred AhlholmExecutive Officer
- Remy LuthringerExecutive Officer, Director
- Mark LevineExecutive Officer
- Michele OllierDirector
- Francesco De RubertisDirector
- Marc BeerDirector
- Offering amount
- $31M
- Amount sold
- $31M
- Sales commissions
- $2.2M
- Placement agents
- Jefferies LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$109.7Mvaluation at IPOJul 2014 · $6.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 3
by search overlap
Robinhood27 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView23 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
StockTwits21 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies competing with Minerva Neurosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Minerva Neurosciences posts Q2 profit on warrant swing | NERV Quarterly Report (10-Q)stocktitan.net · Aug 2026Frequently asked questions
- What does Minerva Neurosciences do?
- Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders. It focuses on designing clinical trials with endpoints tied to patient benefit.
- Who are Minerva Neurosciences's investors?
- Minerva Neurosciences's investors include Vivo Capital, Care Capital, Index Ventures, Medicxi.
- How much funding has Minerva Neurosciences raised?
- Minerva Neurosciences has disclosed $32M raised across 2 of its 4 known rounds.
- Where is Minerva Neurosciences headquartered?
- Minerva Neurosciences is headquartered in Waltham, US.